Multi-omics fusion analysis models with machine learning predict survival of HER2-negative metastatic breast cancer : a multicenter prospective observational study
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:136 |
|---|---|
| Enthalten in: |
Chinese medical journal - 136(2023), 7 vom: 05. Apr., Seite 863-865 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wang, Jiani [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
EC 2.7.10.1 |
|---|
| Anmerkungen: |
Date Completed 01.05.2023 Date Revised 13.08.2023 published: Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1097/CM9.0000000000002625 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM355320525 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM355320525 | ||
| 003 | DE-627 | ||
| 005 | 20231226064111.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1097/CM9.0000000000002625 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1184.xml |
| 035 | |a (DE-627)NLM355320525 | ||
| 035 | |a (NLM)37027394 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wang, Jiani |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Multi-omics fusion analysis models with machine learning predict survival of HER2-negative metastatic breast cancer |b a multicenter prospective observational study |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.05.2023 | ||
| 500 | |a Date Revised 13.08.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Trastuzumab |2 NLM | |
| 650 | 7 | |a P188ANX8CK |2 NLM | |
| 650 | 7 | |a Receptor, ErbB-2 |2 NLM | |
| 650 | 7 | |a EC 2.7.10.1 |2 NLM | |
| 700 | 1 | |a Liu, Yuwei |e verfasserin |4 aut | |
| 700 | 1 | |a Zhang, Renzhi |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Zhenyu |e verfasserin |4 aut | |
| 700 | 1 | |a Yi, Zongbi |e verfasserin |4 aut | |
| 700 | 1 | |a Guan, Xiuwen |e verfasserin |4 aut | |
| 700 | 1 | |a Zhao, Xinming |e verfasserin |4 aut | |
| 700 | 1 | |a Jiang, Jingying |e verfasserin |4 aut | |
| 700 | 1 | |a Tian, Jie |e verfasserin |4 aut | |
| 700 | 1 | |a Ma, Fei |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Chinese medical journal |d 1979 |g 136(2023), 7 vom: 05. Apr., Seite 863-865 |w (DE-627)NLM000002755 |x 2542-5641 |7 nnns |
| 773 | 1 | 8 | |g volume:136 |g year:2023 |g number:7 |g day:05 |g month:04 |g pages:863-865 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1097/CM9.0000000000002625 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 136 |j 2023 |e 7 |b 05 |c 04 |h 863-865 | ||